The tiny Himalayan kingdom wedged between India and China has vaccinated nearly 93 per cent of its adult population since March 27.
Australia will not buy the Johnson & Johnson COVID-19 vaccine because it is a similar type to the AstraZeneca one being manufactured locally.
- by Rachel Clun
The rules, which are expected to be implemented over the next fortnight, will be similar to existing rules requiring aged care workers to get flu vaccinations before taking on jobs in nursing homes.
- by Hamish Hastie
Israel’s Green Pass allows holders to dine indoors, stay in hotels, visit gyms, and attend large events.
- by Campbell MacDiarmid and Quique Kierszenbaum
NSW Health has said new advice regarding use of the AstraZeneca vaccine in people under 50 will cause “significant challenges” for the Australian rollout.
- by Mary Ward and Lucy Cormack
China’s top disease control official has said the country is formally considering mixing COVID-19 vaccines, as a way of further boosting vaccine efficacy.
- by Joe McDonald and Huizhong Wu
NSW Premier Gladys Berejiklian has called for a greater urgency on the rollout to avoid being left behind the rest of the world.
- by Lucy Cormack and Mary Ward
Failing to speed up the vaccination rollout could leave Australians facing up to 34 extra days under lockdown.
- by Jennifer Duke
Economists don’t know what the future holds. But that doesn’t mean their forecasts are worthless.
- by Jennifer Duke
With misinformation spreading like wildfire across social media, fact-checking the fact-checkers is vital during the vaccination stage of the pandemic.
- by Andrew Moshirnia
Federal Health Minister Greg Hunt said he was also pleased with vaccination numbers over the weekend and expressed confidence additional Pfizer doses would be delivered.
- by Ashleigh McMillan and Nick Bonyhady